A modified 45S5 Bioglass® containing 2 mol% alumina and strontium oxide was prepared. In vitro bioactivity in powder monolithic samples conducted. Fourier transform infrared analysis pH change simulated body fluid were investigated for after 480 min of immersion. Additionally, X-ray diffraction scanning electron microscopy 7 14 days immersion samples. The formation phosphate carbonate phase pre...

The injectable composites were formulated from melt-derived 45S5 bioactive glass powder and gum tragacanth. The effect of tragacanth concentration (2 and 4 w/v%) and powder to liquid ratio (P/L= 1.5 to 2.5) on rheological properties, injectability, degradation, swelling, and bioactivity the composites was studied. With the increase of P/L ratio and tragacanth concentration, the force requ...

Bioglass-graphene oxide composites can be served as a high-potential candidate for biomedical applications due to its specific mechanical properties. In this study, the 45S5 bioactive glass (BG) - graphene oxide (GO) composite containing 2 wt. % GO was coated on titanium alloy via electrophoretic deposition process (EPD). The synthesized GO was incorporated into BG coating to improve the mechan...